Praxis Precision Medicines (PRAX)Driehaus Capital Management LLC added to its stake +9,823 shares

959K

Shares reported · +9,823 vs prior quarter

1.9%

Disclosed portfolio weight

$321M

Reported value

Holdings as of

Jun 30, 2026

Filed

Aug 14, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. Jun 29, 2026Company filing · Form 8-K · Auditor changeChanged its auditor“On June 29, 2026, the Audit Committee of the Board of Directors (the "Audit Committee") of Praxis Precision Medicines, Inc. (the "Company") approved the dismissal of Ernst & Young LLP ("EY") as the Company's independent registered public accounting firm, effective as of that date.”
2. Jul 30, 2026CongressDisclosed purchase of PRAX — reported range $1,001 - $15,000
3. Aug 6, 2026Company filing · Form 8-K · Results, Reg FDReported its results, and shared information with investors

How to read SEC Form 13F-HR

Form 13F is the quarterly report in which investment managers that oversee $100 million or more list the US-listed stocks and some other securities they held on the last day of the quarter.

Full guide: What is an SEC Form 13F?

What else is on file for Praxis Precision Medicines

For Praxis Precision Medicines, OQRO holds 1 Congress trade report and 5 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its PRAX page.

How this filing works

• SEC Form 13F

Other disclosures at Praxis Precision Medicines

• House Clerk periodic transaction reportSep 4, 2026
• SEC Form 13F-HRAug 14, 2026
• SEC Form 13F-HRAug 14, 2026
• SEC Form 13F-HRAug 14, 2026
• SEC Form 13F-HRAug 14, 2026
• SEC Form 13F-HRMay 29, 2026

Everything OQRO holds on this company is on its PRAX page.